IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Shelter Pharma IPO is a book build IPO listing on BSE SME exchange. The company is based in Himmatnagar and caters to Pharmaceutical - Ayurvedic sector. Gretex Corporate Services is the merchant banker of Shelter Pharma IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th April 2023.
Shelter Pharma IPO posted revenues of Rs 36.16 crores and PAT of Rs 5.78 crores in FY25 on annualised basis.Financial results of Shelter Pharma IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Shelter Pharma IPO PAT Margin is 15.99%, ROCE (Return on Capital Employed) is [●]% as per latest financial. The below table shows Shelter Pharma IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Shelter Pharma IPO is Rs 48.55 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Shelter Pharma IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Shelter Pharma IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Shelter Pharma IPO is ₹48.55 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Shelter Pharma IPO has a Price-to-Earnings (PE) ratio of 8.40 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Shelter Pharma IPO reported revenue of ₹36.16 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Shelter Pharma IPO provide insights into sales growth, market demand, and business scalability.
Shelter Pharma recorded an EBITDA of ₹ 8.12 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Shelter Pharma Profit After Tax (PAT) is ₹5.78 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 36.15 Cr.
EBITDA Margin:
22.46
%
Net Worth: ₹ 14.51 Cr.
Market Capitalisation:
₹ 48.55 Cr.
P/E:
8.40 times
P/BV: 1.59 times
EV/EBITDA: 6.15 times
Shelter Pharma operates in Pharmaceutical - Ayurvedic and Manufacturing Herbal Products. The Issue is listed on BSE SME in Aug, 2023. Shelter Pharma IPO size was 16.03 with Issue price of 42.00 .
Merchant Banker(s) of Shelter Pharma IPO: Gretex Corporate Services Limited
Shelter Pharma IPO subscription was 15.25 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Shelter Pharma IPO listed at a listing price of 41.96 against the offer price of 42.00.
The current market price of Shelter Pharma is 39.19.
Why Us?
